Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists probe immune cells behind rare anemia

NCT ID NCT02158195

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire Dijon Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at how certain immune cells, called T cells, behave in people with autoimmune hemolytic anemia, a condition where the body attacks its own red blood cells. Researchers compared blood samples from 27 patients and healthy volunteers to understand the disease better. The goal was to learn more about what goes wrong in the immune system, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could improve understanding of how the immune system attacks red blood cells in autoimmune hemolytic anemia, potentially pointing toward new treatment targets.
What could go wrong
This is an observational study with only 27 participants, so findings may not apply to all patients. It does not test a new treatment, so direct benefits are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOIMMUNE HEMOLYTIC ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune hemolytic anemia autoimmune hemolytic anemia, warm type

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTOIMMUNE HEMOLYTIC ANEMIA

Contacts and locations

Locations

  • CH de Chalon-sur-Saône

    Chalon-sur-Saône, 71100, France

  • CH de METZ

    Metz, 57000, France

  • CH de Mâcon

    Mâcon, 71018, France

  • CHU de Besançon

    Besançon, 25030, France

  • CHU de DIJON

    Dijon, 21079, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.